This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

LSX USA Congress
Life Science Executive Partnering
Congress Sept 23-24, Forums Sept 22, 2026Hynes Convention Center, Boston, USA

Mr Aryeh Ganz
Managing Partner at Cornucopian Capital
Speaker

Profile

Aryeh founded Cornucopian Capital with a vision to make impact-driven investments in companies advancing the future of “Medicine 3.0” — predictive, preventative, personalized, and participatory healthcare – investing in and building companies that deliver more individualized care, develop novel foods and bioactive ingredients, pioneer new therapeutic platforms, and create technologies that measure and make sense of the body in real time. He’s also a co-founder and managing partner of Barnstorm Foundry, a Bay Area-based venture studio for Medicine 3.0 startups. Through Barnstorm Foundry, he forged a groundbreaking relationship with the University of California at Davis (UCD), a global leader in biological sciences and engineering, where he currently serves on the board of UCD’s Innovation Institute for Food and Health. Aryeh also serves as the Investment Manager of the New Jersey Innovation Institute’s Venture Studio. He is the principal of SAGEN Trust Company, Inc., a private family office established in 2001 following his family’s sale of Slim Fast Foods, and has founded numerous companies, non-profits and philanthropic initiatives in Israel, the U.S. and the U.K.

Agenda Sessions

  • Signal over Noise: Crafting Investable Science in Shifting Markets

    3:35pm